BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 19194534)

  • 1. Predictors of outcome and the lack of effect of percutaneous coronary intervention across the risk strata in patients with persistent total occlusion after myocardial infarction: Results from the OAT (Occluded Artery Trial) study.
    Kruk M; Kadziela J; Reynolds HR; Forman SA; Sadowski Z; Barton BA; Mark DB; Maggioni AP; Leor J; Webb JG; Kapeliovich M; Marin-Neto JA; White HD; Lamas GA; Hochman JS
    JACC Cardiovasc Interv; 2008 Oct; 1(5):511-20. PubMed ID: 19194534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Causes of death in early MI survivors with persistent infarct artery occlusion: results from the Occluded Artery Trial (OAT).
    Lang IM; Forman SA; Maggioni AP; Ruzyllo W; Renkin J; Vozzi C; Steg PG; Hernandez-Garcia JM; Zmudka K; Jimenez-Navarro M; Sopko G; Lamas GA; Hochman JS
    EuroIntervention; 2009 Nov; 5(5):610-8. PubMed ID: 20142183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary intervention for persistent occlusion after myocardial infarction.
    Hochman JS; Lamas GA; Buller CE; Dzavik V; Reynolds HR; Abramsky SJ; Forman S; Ruzyllo W; Maggioni AP; White H; Sadowski Z; Carvalho AC; Rankin JM; Renkin JP; Steg PG; Mascette AM; Sopko G; Pfisterer ME; Leor J; Fridrich V; Mark DB; Knatterud GL;
    N Engl J Med; 2006 Dec; 355(23):2395-407. PubMed ID: 17105759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous Coronary Intervention Versus Optimal Medical Therapy for Chronic Total Coronary Occlusion With Well-Developed Collaterals.
    Choi SY; Choi BG; Rha SW; Baek MJ; Ryu YG; Park Y; Byun JK; Shim M; Li H; Mashaly A; Jang WY; Kim W; Choi JY; Park EJ; Na JO; Choi CU; Lim HE; Kim EJ; Park CG; Seo HS; Oh DJ
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28903939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous coronary intervention in the Occluded Artery Trial: procedural success, hazard, and outcomes over 5 years.
    Buller CE; Rankin JM; Carere RG; Buszman PE; Pfisterer ME; Dzavik V; Thomas B; Forman S; Ruzyllo W; Mancini GB; Michalis LK; Abreu PF; Lamas GA; Hochman JS
    Am Heart J; 2009 Sep; 158(3):408-15. PubMed ID: 19699864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late percutaneous coronary intervention for the totally occluded infarct-related artery: a meta-analysis of the effects on cardiac function and remodeling.
    Appleton DL; Abbate A; Biondi-Zoccai GG
    Catheter Cardiovasc Interv; 2008 May; 71(6):772-81. PubMed ID: 18415952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infarct artery distribution and clinical outcomes in occluded artery trial subjects presenting with non-ST-segment elevation myocardial infarction (from the long-term follow-up of Occluded Artery Trial [OAT]).
    Menon V; Ruzyllo W; Carvalho AC; Almeida de Sousa JM; Forman SA; Jaworska K; Lamas GA; Roik M; Thuaire C; Turgeman Y; Hochman JS
    Am J Cardiol; 2013 Apr; 111(7):930-5. PubMed ID: 23351464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of female sex to outcomes after myocardial infarction with persistent total occlusion of the infarct artery: analysis of the Occluded Artery Trial (OAT).
    Reynolds HR; Forman SA; Tamis-Holland JE; Steg PG; Mark DB; Pearte CA; Carvalho AC; Sopko G; Liu L; Lamas GA; Kruk M; Loboz-Grudzien K; Ruzyllo W; Hochman JS
    Am Heart J; 2012 Mar; 163(3):462-9. PubMed ID: 22424018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is an occluded artery better than an open one?
    Antoniucci D
    JACC Cardiovasc Interv; 2008 Oct; 1(5):521-3. PubMed ID: 19463353
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term effects of percutaneous coronary intervention of the totally occluded infarct-related artery in the subacute phase after myocardial infarction.
    Hochman JS; Reynolds HR; Dzavík V; Buller CE; Ruzyllo W; Sadowski ZP; Maggioni AP; Carvalho AC; Rankin JM; White HD; Goldberg S; Forman SA; Mark DB; Lamas GA;
    Circulation; 2011 Nov; 124(21):2320-8. PubMed ID: 22025606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reinfarction after percutaneous coronary intervention or medical management using the universal definition in patients with total occlusion after myocardial infarction: results from long-term follow-up of the Occluded Artery Trial (OAT) cohort.
    White HD; Reynolds HR; Carvalho AC; Pearte CA; Liu L; Martin CE; Knatterud GL; Džavík V; Kruk M; Steg PG; Cantor WJ; Menon V; Lamas GA; Hochman JS
    Am Heart J; 2012 Apr; 163(4):563-71. PubMed ID: 22520521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of left ventricular ejection fraction on clinical outcomes over five years after infarct-related coronary artery recanalization (from the Occluded Artery Trial [OAT]).
    Kruk M; Buller CE; Tcheng JE; Dzavík V; Menon V; Mancini GB; Forman SA; Kurray P; Busz-Papiez B; Lamas GA; Hochman JS
    Am J Cardiol; 2010 Jan; 105(1):10-6. PubMed ID: 20102883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiological effects of late percutaneous coronary intervention for infarct-related coronary artery occlusion: the Occluded Artery Trial-Electrophysiological Mechanisms (OAT-EP).
    Rashba EJ; Lamas GA; Couderc JP; Hollist SM; Dzavik V; Ruzyllo W; Fridrich V; Buller CE; Forman SA; Kufera JA; Carvalho AC; Hochman JS;
    Circulation; 2009 Feb; 119(6):779-87. PubMed ID: 19188505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart failure in post-MI patients with persistent IRA occlusion: prevalence, risk factors, and the long-term effect of PCI in the Occluded Artery Trial (OAT).
    Jhaveri RR; Reynolds HR; Katz SD; Jeger R; Zinka E; Forman SA; Lamas GA; Hochman JS
    J Card Fail; 2012 Nov; 18(11):813-21. PubMed ID: 23141853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of benefit with percutaneous intervention for late persistent occlusion after myocardial infarction: summary of the occluded artery trial.
    Gimple S; Menon V
    J Cardiovasc Nurs; 2008; 23(1):30-3. PubMed ID: 18158504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Chronic Total Occlusion in a Noninfarct-related Artery on Clinical Outcomes in Patients With Acute ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Zhang HP; Zhao Y; Li H; Tang GD; Ai H; Zheng NX; Liu JH; Sun FC
    Medicine (Baltimore); 2016 Jan; 95(2):e2441. PubMed ID: 26765429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of collateral flow to the occluded infarct-related artery on clinical outcomes in patients with recent myocardial infarction: a report from the randomized occluded artery trial.
    Steg PG; Kerner A; Mancini GB; Reynolds HR; Carvalho AC; Fridrich V; White HD; Forman SA; Lamas GA; Hochman JS; Buller CE;
    Circulation; 2010 Jun; 121(25):2724-30. PubMed ID: 20547926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of timing, location and definition of reinfarction on mortality in patients with totally occluded infarct related arteries late after myocardial infarction.
    Adlbrecht C; Huber K; Reynolds HR; Carvalho AC; Džavík V; Steg PG; Liu L; Marino P; Pearte CA; Rankin JM; White HD; Lamas GA; Hochman JS
    Int J Cardiol; 2014 Jun; 174(1):90-5. PubMed ID: 24726166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced-dose fibrinolytic acceleration of ST-segment elevation myocardial infarction treatment coupled with urgent percutaneous coronary intervention compared to primary percutaneous coronary intervention alone results of the AMICO (Alliance for Myocardial Infarction Care Optimization) Registry.
    Denktas AE; Athar H; Henry TD; Larson DM; Simons M; Chan RS; Niles NW; Thiele H; Schuler G; Ahn C; Sdringola S; Anderson HV; McKay RG; Smalling RW
    JACC Cardiovasc Interv; 2008 Oct; 1(5):504-10. PubMed ID: 19463352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the effect of a concurrent chronic total occlusion on long-term mortality and left ventricular function in patients after primary percutaneous coronary intervention.
    Claessen BE; van der Schaaf RJ; Verouden NJ; Stegenga NK; Engstrom AE; Sjauw KD; Kikkert WJ; Vis MM; Baan J; Koch KT; de Winter RJ; Tijssen JG; Piek JJ; Henriques JP
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1128-34. PubMed ID: 19926056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.